ACTA1 and ameloblastoma: Of the 15 samples of solid ameloblastoma, 1 case (6.7%) showed no expression of α-SMA; 9 cases (60%) revealed weak expression; and 5 samples (33.3%) showed strong expression of α-SMA, indicating a relatively high expression of α-SMA in solid ameloblastomas.